|

| 产地 | 进口、国产 |
| 品牌 | 上海莼试 |
| 保存条件 | Store at -20 °C |
| 货号 | CS10605 |
| 应用范围 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
| CAS编号 | |
| 抗体名 | Anti-Phospho-PAK1(Thr423)/PAK2 (Thr402) |
| 克隆性 | |
| 靶点 | 详见说明书 |
| 适应物种 | 详见说明书 |
| 形态 | 详见说明书 |
| 宿主 | 详见说明书 |
| 亚型 | IgG |
| 标识物 | 详见说明书 |
| 浓度 | 1mg/1ml% |
| 免疫原 | KLH conjugated Synthesised phosphopeptide derived from human PAK1 around the phosphorylation site of Thr423 |
产品订购信息:
英文名称 Anti-Phospho-PAK1(Thr423)/PAK2 (Thr402)
中文名称 磷酸化p21激活激酶1/2抗体费用
别 名 Pak2(phospho T402); Pak1(phospho T423); PAK1(phospho T402); PAK2(phospho T423); PAKalpha; serine/threonine-protein kinase PAK 1; p21 activated kinase 1; PAK alpha; Paka; PAKalpha; Protein kinase MUK2; STE20 homolog (yeast); Alpha PAK; p21/Cdc42/Rac1 activated kinase 1; CB422; EC 2.7.11.1; Gamma PAK; hPAK65; Kinase; p21 (CDKN1A)-activated kinase 2a; p21 activated kinase 2; p21 protein (Cdc42/Rac)-activated kinase 2; p21 protein Cdc42 Rac activated kinase 2; p21-activated kinase, 65-KD; p21-activated protein kinase I; p21CDKN1A activated kinase 2; p58; p65PAK; PAK 2; PAK65; PAKgamma; S6 H4 kinase; Serine threonine protein kinase PAK 2; Serine/threonine-protein kinase PAK 3; p21-activated kinase 3; PAK-3; Beta-PAK; PAK1_HUMAN; PAK2_HUMAN.


浓 度 1mg/1ml
规 格 0.1ml/100μg
抗体来源 Rabbit
克隆类型 polyclonal
交叉反应 Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Rabbit
产品类型 一抗 磷酸化抗体
研究领域 免疫学 信号转导 细胞凋亡 转录调节因子 激酶和磷酸酶
蛋白分子量 predicted molecular weight: 60kDa
性 状 Lyophilized or Liquid
免 疫 原 KLH conjugated Synthesised phosphopeptide derived from human PAK1 around the phosphorylation site of Thr423
亚 型 IgG
纯化方法 affinity purified by Protein A
储 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
磷酸化p21激活激酶1/2抗体费用 产品应用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
(石蜡切片需做抗原修复)
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存条件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
产品介绍 In mammals, there are several identified isoforms of p21 Activated Protein Kinases or PAKs: PAK1 and PAK3 are mostly brain specific, while PAK2 is expressed ubiquitously. Mutations of the gene coding for PAK3 are associated with X linked mental retardation and PAK3 is a key regulator of synapse formation and plasticity in the hippocampus. PAK3 is thought to play a key role in regulation of cell shape and motility as well as cell death. P21-activated kinase (PAK) is actually a family of serine/threonine protein kinases, members of which are activated by small molecular weight GTPases. The three most common isoforms are PAK 1, PAK 2, and PAK 3 (also known as alpha PAK, gamma PAK, and beta PAK, respectively). These kinases contain numerous regulatory elements that trigger diverse signaling processes such as those initiated by activated GTPases, interaction with Src homology 3 (SH3) domains, and caspase mediated proteolytic cleavage. Autophosphorylation of serine 141 (serine 144 for PAK 1 and serine 139 PAK 3), catalyzed by Cdc42, is required for activation of PAK.
Function : The activated kinase acts on a variety of targets. Likely to be the GTPase effector that links the Rho-related GTPases to the JNK MAP kinase pathway. Activated by CDC42 and RAC1. Involved in dissolution of stress fibers and reorganization of focal complexes. Involved in regulation of microtubule biogenesis through phosphorylation of TBCB. DVL1 and PAK1 form a ternary complex with MUSK which is important for MUSK-dependent regulation of AChR clustering during the formation of the neuromuscular junction (NMJ). Activity is inhibited in cells undergoing apoptosis, potentially due to binding of CDC2L1 and CDC2L2. Phosphorylates MYL9/MLC2. Phosphorylates RAF1 at 'Ser-338' and 'Ser-339' resulting in: activation of RAF1, stimulation of RAF1 translocation to mitochondria, phosphorylation of BAD by RAF1, and RAF1 binding to BCL2.
Subunit : Homodimer in its autoinhibited state. Active as monomer. Interacts tightly with GTP-bound but not GDP-bound CDC42/P21 and RAC1. Binds to the caspase-cleaved p110 isoform of CDC2L1 and CDC2L2, p110C, but not the full-length proteins. Component of cytoplasmic complexes, which also contain PXN, ARHGEF6 and GIT1. Interacts with ARHGEF7. Also interacts with CRIPAK. Interacts with NISCH. Interacts with DVL1; mediates the formation of a DVL1, MUSK and PAK1 ternary complex involved in AChR clustering. Probably found in a ternary complex composed of DSCAM, PAK1 and RAC1. Interacts with DSCAM (via cytoplasmic domain); the interaction is direct and enhanced in presence of RAC1. Interacts with SCRIB. Interacts with PDPK1. Interacts (via kinase domain) with RAF1. Interaction with NCK1 and NCK2.
Subcellular Location : Cytoplasm. Cell junction, focal adhesion. Note=Recruited to focal adhesions upon activation.
Similarity : Belongs to the protein kinase superfamily. STE Ser/Thr protein kinase family. STE20 subfamily.
Contains 1 CRIB domain.
Contains 1 protein kinase domain.
Database links : UniProtKB/Swiss-Prot: Q13153.2
PAK1-3蛋白具有广泛的生物学功能,也是一个保守的丝氨酸/苏氨酸蛋白激酶,参与许多重要的细胞活动。包括细胞骨架的动力学调节,细胞移动,生存和凋亡,细胞周期,基因转录调节,细胞生长信号转导和转化等。

Anti-EGF/FITC 荧光素标记表皮生长因子抗体(大鼠)IgGMulti-class antibodies规格: 0.2ml
Anti-HAVCR1/KIM1/TIM1/FITC 荧光素标记病毒细胞受体1IgGMulti-class antibodies规格: 0.2ml
Rhesus antibody Rh C20orf194 20号染色体开放阅读框194抗体 规格 0.2ml
Trk C 神经生长因子受体的一种(抗原) 0.5mg
HSD3a 英文名称: 羟基类固醇脱氢酶3α抗体 0.2ml
Rhesus antibody Rh S100A14 S100A14/15抗体 规格 0.1ml
Anti-HAVCR1/KIM1/TIM1/FITC 荧光素标记病毒细胞受体1IgGMulti-class antibodies规格: 0.2ml
Anti-Phospho-Lyn (Tyr507) /FITC 荧光素标记膜相关蛋白酪氨酸激酶Lyn抗体IgGMulti-class antibodies规格: 0.2ml
Anti-phospho-Tau protein (Ser422)/FITC 荧光素标记磷酸化微管相关蛋白抗体IgGMulti-class antibodies规格: 0.2ml
Rhesus antibody Rh ADCK3/CABC1 伴侣蛋白bc1同源复合体抗体 规格 0.2ml
Rabbit Anti-dog IgG/FITC FITC标记的兔抗狗IgG 0.3ml
GBP5 英文名称: G蛋白结合蛋白5抗体 0.2ml
Rhesus antibody Rh Rabbit Anti-chicken IgG/Cy7 Cy7标记的兔抗鸡IgG 规格 0.1ml
Anti-phospho-Tau protein (Ser422)/FITC 荧光素标记磷酸化微管相关蛋白抗体IgGMulti-class antibodies规格: 0.2ml
DUTP(Human deoxyuridinetriphate) ELISA Kit 人脱氧尿三磷酸Multi-class antibodies规格: 48T
Anti-PDGF-A 血小板源性生长因子-A抗体Multi-class antibodies规格: 0.1ml
Rhesus antibody Rh HMGB4 高迁移率族蛋白B4抗体 规格 0.1ml
AIRA(Human anti-insulin receptor antibody) ELISA Kit 人抗受体抗体 96T
phospho-PFKL (Ser775) 英文名称: 磷酸化6磷酸果糖激酶抗体 0.1ml
C1orf31 英文名称: 1号染色体开放阅读框31抗体 0.2ml
Anti-PDGF-A 血小板源性生长因子-A抗体Multi-class antibodies规格: 0.1ml
CL-0316A7r5(大鼠胸大动脉平滑肌细胞)5×106cells/瓶×2
CD63 Others Rat 大鼠 CD63 / Tspan-30 / Teaspanin-30 人细胞裂解液 (阳性对照)
人海马趾星形胶质细胞总RNAHA-h NA
盘羊皮肤细胞;ASHS3 卵巢细胞,Lec1细胞 L7712细胞,615小鼠T细胞性瘤株
SV40T转化的人胚肾细胞;293T
HA Others H5N1 甲型 H5N1 (A/Egypt/N05056/2009) 血凝素 (Hemagglutinin / HA) 人细胞裂解液 (阳性对照)
CL-03142V6.11(人胚肾细胞)5×106cells/瓶×2
HA Others H7N7 甲型 H7N7 (A/chicken/Netherlands/1/03) 血凝素 (Hemagglutinin / HA) 杆状病毒-昆虫细胞裂解液 (阳性对照)
人小脑星形胶质细胞总RNAHA-c NA
J82细胞,细胞 人胚肺细胞,WI-38细胞 原代系膜细胞特制基础无血清培养基Many types of cells包装:500/100ml
豹猫肌肉成纤维样细胞;LCM4
WISP1 Others Human 人 WISP1 / CCN4 人细胞裂解液 (阳性对照)
磷酸化p21激活激酶1/2抗体费用 SRC Others Human 人 SRC Kinase / Proto-oncogene c-Src 杆状病毒-昆虫细胞裂解液 (阳性对照)
Asp2人胚胎肾细胞转化细胞;FC33
CM-H022人成纤维细胞完全培养基100mL
kasumi-1, 人细胞株 横纹肌癌细胞,A673细胞 稳定表达EBNA1的人胚肾细胞;293E
615小鼠株;Ca759
OSTM1 Others Human 人 OSTM1 人细胞裂解液 (阳性对照)

抗体的生物素化标记实验要点:
1. 磷酸化p21激活激酶1/2抗体费用 如在反应混合液中有叠氮钠或游离氨基存在,会抑制标记反应。因此,蛋白质在反应前要对 0.1mol/L碳酸氢钠缓冲液或0.5mol/L硼酸缓冲液充分透析;
2.所用的NHSB及待生物素化蛋白质之间的分子比按蛋白质表面的ε-氨基的密度会有所不同,选择不当则影响标记的效率,应先用几个不同的分子比来筛选最适条件;
3.用NHSB量过量也是不利的,抗原的结合位点可能因此被封闭,导致抗体失活;
4.由于抗体的氨基不易接近可能造成生物素化不足,此时可加入去污剂如 Triton x-100, Tween20等;
5.当游离ε-氨基(赖氨酸残基的氨基)存在于抗体的抗原结合位点时,或位于酶的催化位点时,生物素化会降低或损伤抗体蛋白的结合力或活性;
6.生物素还可能与不同的功能基团,如羰基、氨基、巯基、异咪唑基及*基,也可与糖基共价结合;
7.交联反应后,应充分透析,否则,残余的生物素会对生物素化抗体与亲和素的结合产生竞争作用;
8.在细胞的荧光标记实验中,中和亲和素的本底低,但由于链霉亲和素含有少量正电荷,故对某些细胞可导致高本底。
抗体的鉴定:
1)磷酸化p21激活激酶1/2抗体费用 抗体的效价鉴定:不管是用于诊断还是用于,制备抗体的目的都是要求较高效价。不同的抗原制备的抗体,要求的效价不一。鉴定效价的方法很多,包括有试管凝集反应,琼脂扩散试验,酶联免疫吸附试验等。常用的抗原所制备的抗体一般都有约成的鉴定效价的方法,以资比较。如制备抗抗体的效价,一般就采用琼脂扩散试验来鉴定。
2)抗体的特异性鉴定:抗体的特异性是指与相应抗原或近似抗原物质的识别能力。抗体的特异性高,它的识别能力就强。衡量特异性通常以交叉反应率来表示。交叉反应率可用竞争抑制试验测定。以不同浓度抗原和近似抗原分别做竞争抑制曲线,计算各自的结合率,求出各自在IC50时的浓度,并按公式计算交叉反应率。
如果所用抗原浓度IC50浓度为pg/管,而一些近似抗原物质的IC50浓度几乎是无穷大时,表示这一抗血清与其他抗原物质的交叉反应率近似为0,即该血清的特异性较好。
3)抗体亲和力:是指抗体和抗原结合的牢固程度。亲和力的高低是由抗原分子的大小,抗体分子的结合位点与抗原决定簇之间立体构型的合适度决定的。有助于维持抗原抗体复合物稳定的分子间力有氢键,疏水键,侧链相反电荷基因的库仑力,范德华力和空间斥力。亲和力常以亲和常数K表示,K的单位是L/mol。抗体亲和力的测定对抗体的筛选,确定抗体的用途,验证抗体的均一性等均有重要意义。